---
document_datetime: 2023-09-21 17:48:49
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/emtriva-epar-all-authorised-presentations_en.pdf
document_name: emtriva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8894955
conversion_datetime: 2025-12-20 14:29:03.929508
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical form   | Route of administration   | Packaging                           | Concentration   | Package size   |
|-----------------|-----------------|------------|-----------------------|---------------------------|-------------------------------------|-----------------|----------------|
| EU/1/03/261/001 | Emtriva         | 200 mg     | Capsule, hard         | Oral use                  | Bottle (HDPE)                       |                 | 30 capsules    |
| EU/1/03/261/002 | Emtriva         | 200 mg     | Capsule, hard         | Oral use                  | Blister (Aclar/polyethylene/PVC)    |                 | 30 capsules    |
| EU/1/03/261/003 | Emtriva         | 10 mg/ml   | Oral solution         | Oral use                  | Bottle (polyethylene terephthalate) | 10 mg/ml        | 1 bottle       |